Source:http://linkedlifedata.com/resource/pubmed/id/17581616
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2007-11-16
|
pubmed:abstractText |
The tight-skin (TSK/+) mouse, a genetic model for systemic sclerosis (SSc), develops cutaneous fibrosis and autoimmunity. Although immunological abnormalities have been demonstrated in TSK/+ mice, the roles of B-cell-activating factor belonging to the tumor necrosis factor family (BAFF), a potent B-cell survival factor, have not been investigated. Serum BAFF levels in TSK/+ mice were examined by ELISA. Newborn TSK/+ mice were treated with BAFF antagonist, and then skin fibrosis of 8-week-old mice was assessed. Serum BAFF levels were significantly elevated in TSK/+ mice. Remarkably, BAFF antagonist inhibited the development of skin fibrosis, hyper-gamma-globulinemia, and the autoantibody production in TSK/+ mice. The skin from TSK/+ mice showed upregulated expressions of fibrogenic cytokines, such as IL-6 and IL-10, while BAFF antagonist significantly suppressed them. Reciprocally, BAFF antagonist augmented antifibrogenic cytokines, such as IFN-gamma, in the skin of TSK/+ mice. Furthermore, TSK/+ B cells with BAFF stimulation had a significantly enhanced ability to produce IL-6. The results suggest that BAFF/BAFF receptor system is critical for the development of skin fibrosis in TSK/+ mice and could be a potent therapeutical target.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1523-1747
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2772-80
|
pubmed:meshHeading |
pubmed-meshheading:17581616-Animals,
pubmed-meshheading:17581616-Autoantibodies,
pubmed-meshheading:17581616-B-Cell Activating Factor,
pubmed-meshheading:17581616-B-Cell Activation Factor Receptor,
pubmed-meshheading:17581616-B-Lymphocytes,
pubmed-meshheading:17581616-Cytokines,
pubmed-meshheading:17581616-Female,
pubmed-meshheading:17581616-Fibrosis,
pubmed-meshheading:17581616-Gene Expression Regulation,
pubmed-meshheading:17581616-Genotype,
pubmed-meshheading:17581616-Mice,
pubmed-meshheading:17581616-Mice, Inbred C57BL,
pubmed-meshheading:17581616-Mice, Transgenic,
pubmed-meshheading:17581616-Models, Biological,
pubmed-meshheading:17581616-Skin
|
pubmed:year |
2007
|
pubmed:articleTitle |
BAFF antagonist attenuates the development of skin fibrosis in tight-skin mice.
|
pubmed:affiliation |
Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|